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Catechol-O-methyltransferase (COMT) is 
an extremely well characterized enzyme that 
degrades catecholamines. A common cod-
ing polymorphism (rs4680; Val158Met) in 
the human COMT gene has been associated 
with a diverse array of phenotypes including 
personality, cognition, pain sensitivity, and 
risk for psychiatric disorders (Tunbridge 
et al., 2006; Sheldrick et al., 2008; Wray 
et al., 2008; Andersen and Skorpen, 2009). 
The Val allele has been associated with an 
advantage in stress resiliency (warrior strat-
egy), while the Met allele has been associ-
ated with increased anxiety and cognitive 
performance (worrier strategy; Goldman 
et al., 2005; Stein et al., 2006).
Three independent groups have just 
reported the presence of a common poly-
morphism in Comt1, which is the mouse 
homologue of COMT (Kember et al., 2010; 
Li et al., 2010; Segall et al., 2010). This pol-
ymorphism (Comt1B2i; MGI:4819952) was 
shown to influence Comt1 mRNA abun-
dance, protein levels, enzymatic activity, and 
behavioral phenotypes. Using a combina-
tion of extant and novel data from panels of 
inbred strains, recombinant inbred strains, 
and outbred heterogeneous stocks, they 
showed associations between the presence 
of a B2 SINE element and numerous com-
plex traits including pain sensitivity, novel 
object exploration, anxiety-like behavior, 
general activity, response to haloperidol 
and chlordiazepoxide, and dopamine D1 
and D2 receptor binding.
All three studies share two common 
jumping-off points: the observation of 
a robust cis-eQTL for Comt1 and prior 
knowledge of its function. These fac-
tors focused their attention on a region 
that was not highly polymorphic among 
the inbred mice they were studying, and 
might otherwise have been ignored. The 
eQTL data were initially confusing because 
probesets that targeted the 3′ UTR showed 
that one group of strains had lower expres-
sion, while probesets that targeted more 5′ 
exons showed expression differences in the 
opposite direction. All three groups traced 
these expression differences to the inser-
tion of a B2 SINE element in the 3′ UTR. 
Insertion of a B2 SINE element produces a 
truncated mRNA that lacks the most distal 
3′ region. Thus, the distal 3′ region was 
much more abundant in strains lacking 
the insertion. Probes targeting the more 
5′ exons provided an assay for overall 
mRNA abundance, which was increased by 
insertion of a B2 SINE element, and thus 
showed a change in the opposite direc-
tion. Studies using RNA sequencing may 
one day provide a more holistic picture 
of gene expression traits that may help to 
more rapidly unravel similar situations. Li 
et al. (2010) explored this possibility, but 
alignment was difficult because the refer-
ence genome (based on C57BL/6J) con-
tained a B2 SINE element. 
Gene expression differences that are 
the result of SINE element insertions are 
likely to be a recurrent theme in the study 
of complex traits. Current estimates sug-
gest that about a million B1 and B2 SINE 
elements are present in the mouse genome 
and the story is similar in other species; the 
SINE element Alu makes up an estimated 
10% of the human genome. Furthermore, 
approximately 5% of mouse genes have 
been estimated to have SINE element 
insertions in the 3′ region (Lee et al., 2008), 
suggesting that we have probably not heard 
the last of their impact on complex traits.
Because the role of COMT in the 
metabolizing catecholamines was first 
described more than 50 years ago by Nobel 
Laureate Julius Axelrod (Axelrod, 1957), it 
could be argued that these papers do not 
provide any novel or fundamental insight 
into the genetic control of behavior; the 
same could be said of earlier studies of 
the Val/Met COMT polymorphism in 
humans. This is not entirely fair: it is by 
experimental manipulation, either man-
made or naturally occurring, that we come 
to understand function of genes, and the 
present studies exemplify this. Moreover, 
these three studies undoubtedly provide 
convincing proof-of-concept (as if it was 
needed) of the enormous and largely 
untapped potential of mouse models to 
identify genes that influence medically 
important phenotypes. We have previously 
used a similar approach to identify a copy 
number variant (CNV) that alters gene 
expression and behavior among inbred and 
outbred mice (Williams 4th et al., 2009). 
It is overwhelmingly likely that numerous 
additional alleles in genes of both known 
and unknown function still await discov-
ery. Resources like panels of inbred strains, 
panels of recombinant inbred strains, the 
collaborative cross, and outbred popula-
tions such as the HS-stock will continue 
to be valuable for these endeavors (Flint, 
2010). Their use in combination with gene 
expression, exhaustive SNP genotyping 
and CNV discovery will continue to move 
our field forward.
A subject that can elicit a spirited debate 
among geneticists of all stripes is the extent 
to which polymorphisms in the same genes 
will influence related traits across species. 
These three papers provide an example of 
a situation in which polymorphisms in a 
gene influence similar traits in both mice 
and humans; however, the picture is not 
completely simple. For example, the Val158 
allele (higher function) and transgenic 
overexpression of the Val158 allele in mice 
have been associated with reduced pain 
sensitivity. Similarly, strains with higher 
Comt1 expression due to the presence of a 
B2 SINE insertion were reported to be less 
sensitive to nociceptive stimuli. However, 
findings regarding anxiety phenotypes are 
more complex and less consistent. While the 
human Met allele (lower function; Enoch 
et al., 2003; Domschke et al., 2004) as well as 
knockout of Comt1 (Gogos et al., 1998) have 
been linked to increased anxiety, strains 
without the SINE element insertion (lower 
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more stringent thresholds for significance 
and will therefore require larger and more 
 powerful samples.
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 generates mRNA variants and causes widespread 
function) showed  inconsistent anxiety-like 
traits: reduced locomotion, increased rear-
ing in the open field, more novel object 
exploration, and reduced time in the light 
compartment in the light/dark test. In sum-
mary, changes in Comt1 expression altered 
many different behaviors in mice but the 
directionality of these differences was only 
somewhat similar to what has been observed 
in humans.
A final word about thresholds for sta-
tistical significance is in order. Had com-
monly accepted standards for genome-wide 
significance been applied in these three 
papers, only the eQTLs would have been 
deemed statistically significant. However, 
there is abundant prior evidence from 
genetic and non-genetic sources, from 
mice and humans, that Comt1 has the 
potential to influence behavioral traits. 
Thus, all three groups incorporated their 
own prior knowledge of this gene in inter-
preting the results of their statistical tests. 
Similarly, the literature regarding the 
Val158Met allele in COMT uses the can-
didate gene approach, where the threshold 
for significance does not correct for all pos-
sible genotype–phenotype tests across the 
genome and is thus many orders of mag-
nitude below that required for significance 
in an unbiased GWAS design. All three of 
these groups essentially performed tests 
under the a priori hypothesis that the eQTL 
for Comt1 would alter behavior. As such, 
they don’t require corrections for genome-
wide testing. Clearly the most exciting dis-
coveries will be those that identify genes 
that have not previously been implicated 
in their respective phenotypes. These 
 breakthroughs will continue to require 
